National Institute of Allergy and Infectious Diseases to Grant Co-Exclusive Patent License for Zika Vaccines

Summary

The National Institute of Allergy and Infectious Diseases is considering granting a co-exclusive patent license to Medigen Vaccines Biologics Corp. and Panacea Biotec Ltd. for the production of monovalent live attenuated Zika vaccines and multivalent live attenuated Zika and dengue vaccines.